Surrozen (SRZN) Other financing activities (2020 - 2026)
Surrozen (SRZN) posted quarterly Other financing activities of $92000.0 for Q1 2026, up 17.95% quarter-over-quarter from $78000.0 in Q4 2025.
Analysis
Surrozen (SRZN) Other financing activities (2020 - 2026) Analysis & Trends
Surrozen's Other financing activities history runs 5 years deep, the most recent figure standing at $92000.0 for Q1 2026.
- In Q1 2026, Other financing activities changed N/A year-over-year to $92000.0; the TTM figure through Mar 2026 stood at $209000.0 (up 435.9% YoY), while the FY2025 annual figure was $87000.0, up 123.08% from the prior year.
- Other financing activities for Q1 2026 stood at $92000.0, up from $78000.0 in the prior quarter.
- The five-year high for Other financing activities was $92000.0 in Q1 2026, with the low at $39000.0 in Q4 2024.
- The 3-year median for Other financing activities is $78000.0 (2025), against an average of $69666.7.
- Peak annual rise in Other financing activities reached 100.0% in 2025, while the deepest fall reached 100.0% in 2025.
- Surrozen's Other financing activities stood at $39000.0 in 2024, then surged by 100.0% to $78000.0 in 2025, then climbed by 17.95% to $92000.0 in 2026.
- Business Quant data shows SRZN's Other financing activities at $92000.0 in Q1 2026, $78000.0 in Q4 2025, and $39000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 10 | Surrozen | 259.62 Mn | 259.62 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.30 Mn |
| Mar 31, 2026 | 3.33 Mn |
| Dec 31, 2025 | 978,000.00 |
| Sep 30, 2025 | 9,000.00 |
| Dec 31, 2024 | 39,000.00 |
| Dec 31, 2021 | 34,000.00 |
| Sep 30, 2021 | 72,000.00 |
| Jun 30, 2021 | 109,000.00 |
| Mar 31, 2021 | 196,000.00 |
| Dec 31, 2020 | 4.34 Mn |